Cargando…
Wellbeing while waiting evaluating social prescribing in CAMHS: study protocol for a hybrid type II implementation-effectiveness study
BACKGROUND: Social prescribing is a mechanism of connecting patients with non-medical forms of support within the community and has been shown to improve mental health and wellbeing in adult populations. In the last few years, it has been used in child and youth settings with promising results. Curr...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170442/ https://www.ncbi.nlm.nih.gov/pubmed/37165351 http://dx.doi.org/10.1186/s12888-023-04758-0 |
_version_ | 1785039227614920704 |
---|---|
author | Fancourt, Daisy Burton, Alexandra Bu, Feifei Deighton, Jessica Turner, Richard Wright, Joely Bradbury, Alexandra Tibber, Marc Talwar, Shivangi Hayes, Daniel |
author_facet | Fancourt, Daisy Burton, Alexandra Bu, Feifei Deighton, Jessica Turner, Richard Wright, Joely Bradbury, Alexandra Tibber, Marc Talwar, Shivangi Hayes, Daniel |
author_sort | Fancourt, Daisy |
collection | PubMed |
description | BACKGROUND: Social prescribing is a mechanism of connecting patients with non-medical forms of support within the community and has been shown to improve mental health and wellbeing in adult populations. In the last few years, it has been used in child and youth settings with promising results. Currently, pathways are being developed for social prescribing in Child and Adolescent Mental Health Services (CAMHS) to support children and young people on treatment waiting lists. The Wellbeing While Waiting study will evaluate whether social prescribing benefits the mental health and wellbeing of children and young people. METHODS: This study utilises an observational, hybrid type II implementation-effectiveness design. Up to ten CAMHS who are developing social prescribing pathways as part of a programme run across England with support from the Social Prescribing Youth Network will participate. Outcomes for children and young people receiving social prescribing whilst on CAMHS waiting lists will be compared to a control group recruited prior to the pathway roll-out. Questionnaire data will be collected at baseline, 3 months and 6 months. Primary outcomes for children and young people are mental health symptoms (including anxiety, depression, stress, emotional and behavioural difficulties). Secondary outcomes include: loneliness, resilience, happiness, whether life is worthwhile, life satisfaction, and service use. An implementation strand using questionnaires and interviews will explore the acceptability, feasibility, and suitability of the pathway, potential mechanisms of action and their moderating effects on the outcomes of interest, as well as the perceived impact of social prescribing. Questionnaire data will be analysed mainly using difference-in-differences or controlled interrupted time series analysis. Interview data will be analysed using reflexive thematic analysis. DISCUSSION: The Wellbeing While Waiting study will provide the first rigorous evidence of the impact of social prescribing for children and young people on waiting lists for mental health treatment. Findings will help inform the prioritisation, commissioning, and running of social prescribing in other CAMHS. To maximise impact, findings will be available on the study website (https://sbbresearch.org) and disseminated via national and international networks. TRIAL REGISTRATION: N/A. |
format | Online Article Text |
id | pubmed-10170442 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101704422023-05-11 Wellbeing while waiting evaluating social prescribing in CAMHS: study protocol for a hybrid type II implementation-effectiveness study Fancourt, Daisy Burton, Alexandra Bu, Feifei Deighton, Jessica Turner, Richard Wright, Joely Bradbury, Alexandra Tibber, Marc Talwar, Shivangi Hayes, Daniel BMC Psychiatry Study Protocol BACKGROUND: Social prescribing is a mechanism of connecting patients with non-medical forms of support within the community and has been shown to improve mental health and wellbeing in adult populations. In the last few years, it has been used in child and youth settings with promising results. Currently, pathways are being developed for social prescribing in Child and Adolescent Mental Health Services (CAMHS) to support children and young people on treatment waiting lists. The Wellbeing While Waiting study will evaluate whether social prescribing benefits the mental health and wellbeing of children and young people. METHODS: This study utilises an observational, hybrid type II implementation-effectiveness design. Up to ten CAMHS who are developing social prescribing pathways as part of a programme run across England with support from the Social Prescribing Youth Network will participate. Outcomes for children and young people receiving social prescribing whilst on CAMHS waiting lists will be compared to a control group recruited prior to the pathway roll-out. Questionnaire data will be collected at baseline, 3 months and 6 months. Primary outcomes for children and young people are mental health symptoms (including anxiety, depression, stress, emotional and behavioural difficulties). Secondary outcomes include: loneliness, resilience, happiness, whether life is worthwhile, life satisfaction, and service use. An implementation strand using questionnaires and interviews will explore the acceptability, feasibility, and suitability of the pathway, potential mechanisms of action and their moderating effects on the outcomes of interest, as well as the perceived impact of social prescribing. Questionnaire data will be analysed mainly using difference-in-differences or controlled interrupted time series analysis. Interview data will be analysed using reflexive thematic analysis. DISCUSSION: The Wellbeing While Waiting study will provide the first rigorous evidence of the impact of social prescribing for children and young people on waiting lists for mental health treatment. Findings will help inform the prioritisation, commissioning, and running of social prescribing in other CAMHS. To maximise impact, findings will be available on the study website (https://sbbresearch.org) and disseminated via national and international networks. TRIAL REGISTRATION: N/A. BioMed Central 2023-05-10 /pmc/articles/PMC10170442/ /pubmed/37165351 http://dx.doi.org/10.1186/s12888-023-04758-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Study Protocol Fancourt, Daisy Burton, Alexandra Bu, Feifei Deighton, Jessica Turner, Richard Wright, Joely Bradbury, Alexandra Tibber, Marc Talwar, Shivangi Hayes, Daniel Wellbeing while waiting evaluating social prescribing in CAMHS: study protocol for a hybrid type II implementation-effectiveness study |
title | Wellbeing while waiting evaluating social prescribing in CAMHS: study protocol for a hybrid type II implementation-effectiveness study |
title_full | Wellbeing while waiting evaluating social prescribing in CAMHS: study protocol for a hybrid type II implementation-effectiveness study |
title_fullStr | Wellbeing while waiting evaluating social prescribing in CAMHS: study protocol for a hybrid type II implementation-effectiveness study |
title_full_unstemmed | Wellbeing while waiting evaluating social prescribing in CAMHS: study protocol for a hybrid type II implementation-effectiveness study |
title_short | Wellbeing while waiting evaluating social prescribing in CAMHS: study protocol for a hybrid type II implementation-effectiveness study |
title_sort | wellbeing while waiting evaluating social prescribing in camhs: study protocol for a hybrid type ii implementation-effectiveness study |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170442/ https://www.ncbi.nlm.nih.gov/pubmed/37165351 http://dx.doi.org/10.1186/s12888-023-04758-0 |
work_keys_str_mv | AT fancourtdaisy wellbeingwhilewaitingevaluatingsocialprescribingincamhsstudyprotocolforahybridtypeiiimplementationeffectivenessstudy AT burtonalexandra wellbeingwhilewaitingevaluatingsocialprescribingincamhsstudyprotocolforahybridtypeiiimplementationeffectivenessstudy AT bufeifei wellbeingwhilewaitingevaluatingsocialprescribingincamhsstudyprotocolforahybridtypeiiimplementationeffectivenessstudy AT deightonjessica wellbeingwhilewaitingevaluatingsocialprescribingincamhsstudyprotocolforahybridtypeiiimplementationeffectivenessstudy AT turnerrichard wellbeingwhilewaitingevaluatingsocialprescribingincamhsstudyprotocolforahybridtypeiiimplementationeffectivenessstudy AT wrightjoely wellbeingwhilewaitingevaluatingsocialprescribingincamhsstudyprotocolforahybridtypeiiimplementationeffectivenessstudy AT bradburyalexandra wellbeingwhilewaitingevaluatingsocialprescribingincamhsstudyprotocolforahybridtypeiiimplementationeffectivenessstudy AT tibbermarc wellbeingwhilewaitingevaluatingsocialprescribingincamhsstudyprotocolforahybridtypeiiimplementationeffectivenessstudy AT talwarshivangi wellbeingwhilewaitingevaluatingsocialprescribingincamhsstudyprotocolforahybridtypeiiimplementationeffectivenessstudy AT hayesdaniel wellbeingwhilewaitingevaluatingsocialprescribingincamhsstudyprotocolforahybridtypeiiimplementationeffectivenessstudy |